Page last updated: 2024-10-31

mianserin and Osteoarthritis

mianserin has been researched along with Osteoarthritis in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Osteoarthritis: A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Okura, T1
Ohkawara, B1
Takegami, Y1
Ito, M1
Masuda, A1
Seki, T1
Ishiguro, N1
Ohno, K1

Other Studies

1 other study available for mianserin and Osteoarthritis

ArticleYear
Mianserin suppresses R-spondin 2-induced activation of Wnt/β-catenin signaling in chondrocytes and prevents cartilage degradation in a rat model of osteoarthritis.
    Scientific reports, 2019, 02-26, Volume: 9, Issue:1

    Topics: Animals; Cartilage, Articular; Chondrocytes; Disease Models, Animal; Female; Male; Mianserin; Osteoa

2019